Overview

the Effect of Calcium Dobesilate on Non Dialysis Patients With CKD

Status:
Unknown status
Trial end date:
2018-12-31
Target enrollment:
0
Participant gender:
All
Summary
To investigate the feasibility of calcium dobesilate in the treatment of microvascular injury provides new ideas and theoretical basis for the prevention and treatment of chronic renal failure.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
The Affiliated Hospital of Xuzhou Medical University
Treatments:
Calcium
Calcium Dobesilate
Calcium, Dietary
Criteria
Inclusion Criteria:

- Enroll the non dialysis patients with chronic renal failure hospitalized in the
Department of Nephrology of the Affiliated Hospital of Xuzhou Medical University.

- According to the glomerular filtration rate, the patients who were not required to be
dialysate were at CKD3-5 (GFR between 10 and 59ml/min).

Exclusion Criteria:

- Exclude those patients with diabetes, cardiovascular disease, severe infection, shock,
dehydration, abnormal liver function, received glucocorticoid therapy, surgery and
emergency dialysis.

- Eliminate those patients with respiratory disease(such as chronic obstructive
pulmonary disease, bronchiectasis, asthma), cardiovascular diseases(such as acute and
chronic cardiac insufficiency), blood system diseases (such as aplastic anemia,
nutritional anemia and polycythemia vera).